ESMO shared critical insights on cancer prevention and control during WHO Regional Office for Europe’s virtual brainstorming session on the development of the Second European Programme of Work 2026-2030 (EPW 2) on 16 January 2025.
ESMO addressed two pivotal health trends and their implications for the region:
Rising cancer cases
Cancer cases are projected to rise by over 20% in Europe by 2045, driven by ageing populations and behavioural and environmental factors.
ESMO emphasised the urgent need for enhanced cancer prevention measures, including stricter tobacco control, food and alcohol labeling, HPV and HBV vaccination coverage, legislation to target air pollution and UV radiation exposures, and protection from occupational carcinogens. Equitable access to cancer care, workforce retention in oncology, and harmonised regulations for innovative cancer treatments were identified as priorities. Delays in cancer clinical trials due fragmented processes, lack of harmonisation, and incomplete infrastructure across countries (e.g. the EU’s In Vitro Diagnostic Medical Devices Regulation IVDR), should be addressed urgently to accelerate patient access to innovative cancer diagnostics and treatments.
Climate crisis and health risks
Climate crisis accelerates the risks of emerging infectious diseases, extreme weather events and related large-scale migration of populations, with severe consequences to health systems.
ESMO called for resilient comprehensive cancer care services during emergencies, alongside mental health support for healthcare workers.
To collectively support these areas, ESMO urged stakeholders to adopt the Society’s cancer resources and prioritise workforce well-being to ensure sustainable health systems.
ESMO continues to contribute to the development of the EPW2 in the run up to the 75th WHO Regional Committee meeting for Europe from 28–30 October 2025 in Copenhagen, Denmark, where the Programme for 2026-2030 is expected to the adopted by the 53 Member States.